Lexaria Bioscience (LEXX) Other Non-Current Assets (2011 - 2020)

Lexaria Bioscience (LEXX) posted Other Non-Current Assets of $49333.0 for Q4 2020, down 53.13% sequentially from $105250.0 in Q3 2020.

Lexaria Bioscience (LEXX) Other Non-Current Assets (2011 - 2020) Analysis & Trends

Lexaria Bioscience has reported Other Non-Current Assets for 3 years, with the latest figure at $49333.0 in Q4 2020.

Quarterly Other Non-Current Assets changed N/A year-over-year to $49333.0 in Q4 2020, while the trailing twelve-month figure through Nov 2020 was $49333.0 (changed N/A YoY) and the FY2020 annual result came in at $105250.0, changed N/A from the prior year.
Other Non-Current Assets eased to $49333.0 in Q4 2020 per LEXX's latest filing, from $105250.0 in the prior quarter.
Over five years, Other Non-Current Assets peaked at $105250.0 in Q2 2020 and troughed at $49333.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	1.25 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	2.31 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	124.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	618.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	109.58 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	65.13 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	202.31 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	104.44 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	62.96 Mn
10	Lexaria Bioscience	10.15 Mn	6.54 Mn	-	-

Download Data